Samsung Bioepis’ Trastuzumab Prequalified By WHO

Ontruzant Is First Ever Biosimilar Prequalified By Organization

 
• By David Wallace
  
WHO
WHO Prequalifies Samsung Bioepis’ Trastuzumab • Source: Shutterstock

More from Biosimilars

More from Products